Cannara Biotech Financials

Cannara Biotech Stock Summary

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. Cannara Biotech is traded on OTC Exchange in the United States.

Cannara Biotech Key Financial Ratios

There are many critical financial ratios that Cannara Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cannara Biotech reports annually and quarterly.

Cannara Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cannara Biotech's current stock value. Our valuation model uses many indicators to compare Cannara Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannara Biotech competition to find correlations between indicators driving Cannara Biotech's intrinsic value. More Info.Cannara Biotech is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.75  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cannara Biotech is roughly  1.33 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cannara Biotech's earnings, one of the primary drivers of an investment's value.

Cannara Biotech Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Cannara Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cannara Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cannara Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Cannara OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cannara Biotech's daily price indicators and compare them against related drivers.

When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.